Novo Nordisk's New Wegovy Subscription: Lower Costs & Predictable Rates
Business & Finance News Today | 2 Min News | The Daily News Now! · The Daily News Now!
Audio is streamed directly from the publisher (api.fastcast.ai) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Novo Nordisk introduces a new subscription program for their Wegovy obesity drugs, offering lower monthly costs for cash-paying customers. The program includes three, six, or twelve-month plans for injections and pills, with longer commitments resulting in bigger discounts. The plans are available through telehealth providers like Ro, WeightWatchers, and Hims and Hers, with flat monthly rates regardless of dose changes. Novo aims to improve patient consistency with these GLP-one drugs, which often face access and side effect challenges. The program initially focuses on higher doses, with lower doses remaining at $149 per month and the four-milligram dose increasing to $199 in August. Novo plans to expand to their own pharmacy platform based on the programs success.
Support the show:
Get a discount at https://solipillow.com/discount/dnn.
Advertise on DNN:
[email protected]
This is an automated, high-level news summary based on public reporting.
Report issues to [email protected].
View sources & latest updates:
https://sources.thednn.ai/386cf48a6b6c3056